TCMBANKIN000138 |
portuliclactone |
|
C20H32O5 |
352.5 g/mol |
CC1CC23CC(CCCC2C1(CCC(=CCO)CO)CO)(OC3=O)C |
TCMBANKIN003265 |
portulal |
|
C20H32O4 |
336.47 |
CC1CC2(CC(=CCCC2C1(CCC(=CCO)CO)CO)C)C=O |
TCMBANKIN007536 |
Portulacaxanthin I |
portulacaxanthin i |
C14H16N2O7 |
324.29 |
C1C(C[N+](=CC=C2CC(NC(=C2)C(=O)O)C(=O)O)C1C(=O)[O-])O |
TCMBANKIN022214 |
Indicaxanthin |
indicaxanthin; (2S)-1-[(2E)-2-[(2S)-2,6-dicarboxy-2,3-dihydro-1H-pyridin-4-ylidene]ethylidene]pyrrolidin-1-ium-2-carboxylate; 2181-75-1; SCHEMBL288232; AC1O1I0D; C08549; CHEBI:5896; (1Z,2S)-1-{(2E)-2-[(2S)-2,6-Dicarboxy-2,3-dihydro-4(1H)-pyridinylidene]ethylidene}-2-pyrrolidinium carboxylate (Indicaxanthin) |
C14H16N2O6 |
308.29 |
C1CC([N+](=CC=C2CC(NC(=C2)C(=O)O)C(=O)O)C1)C(=O)[O-] |
TCMBANKIN022527 |
portulicacid |
|
C17H23N |
|
CC=CC=CC1CCCN1C(C)C2=CC=CC=C2 |
TCMBANKIN029659 |
Poststerone |
(2S,3R,5R,9R,10R,13R,14S,17S)-17-ethanoyl-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; poststerone; ZINC04081397; 10162-99-9; C08837; (2S,3R,5R,9R,10R,13R,14S,17S)-17-acetyl-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one |
C21H30O5 |
362.46 |
CC(=O)C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O |
TCMBANKIN033845 |
betanidin |
betanidin radical |
C18H16N2O8 |
388.3 g/mol |
C1C(N=C(C=C1C=CN2C(CC3=CC(=C(C=C32)O)O)C(=O)O)C(=O)O)C(=O)O |
TCMBANKIN039463 |
Isobetanidin |
|
|
388.33 |
|
TCMBANKIN041485 |
Portulol |
|
|
338.5 g/mol |
|
TCMBANKIN041903 |
Βetanidin |
|
|
|
|
TCMBANKIN043125 |
portulene |
|
C20H32O4 |
336.5 g/mol |
CC1CC(C23CC(=CCCC2C1(CO3)CCC(=CCO)CO)C)O |
TCMBANKIN044023 |
portulenol |
|
C30H33N3O5S |
|
CCOC(=O)C1=C(SC2=C1CCC(C2)C)NC(=O)C3=CC=C(C=C3)OC(C)C(=O)NN=CC4=CC=C(C=C4)C |
TCMBANKIN044382 |
portulaxanthin |
|
C14H17N2O7 |
|
|
TCMBANKIN048766 |
Humilixanthin |
|
|
326.3 g/mol |
|
TCMBANKIN048838 |
Portulenone |
|
|
|
|
TCMBANKIN058530 |
isobetanin |
DTXSID40422525; 15121-53-6; AC1O3DIE; CHEBI:5985; C08551; (2S)-1-[(2E)-2-[(2R)-2,6-dicarboxy-2,3-dihydro-1H-pyridin-4-ylidene]ethylidene]-6-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydroindol-1-ium-2-carboxylate; (E)-1-((E)-2-(2,6-dicarboxy-2,3-dihydropyridin-4(1H)-ylidene)ethylidene)-6-hydroxy-5-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)indolinium-2-carboxylate; betanin; βetanin |
C24H26N2O13 |
550.5 g/mol |
C1C(NC(=CC1=CC=[N+]2C(CC3=CC(=C(C=C32)O)OC4C(C(C(C(O4)CO)O)O)O)C(=O)[O-])C(=O)O)C(=O)O |
TCMBANKIN058531 |
betalamic acid |
betalanic acid;βetalamicacid;Betalamic acid; C08538; (2S,4E)-4-(2-oxoethylidene)-1,2,3,4-tetrahydropyridine-2,6-dicarboxylic acid; CHEMBL2062984; 2,6-Pyridinedicarboxylic acid, 1,2,3,4-tetrahydro-4-(oxoethylidene)-, (S-(E))-; CHEBI:27483; SCHEMBL2186623; AC1NQY5X; 18766-66-0; (S-(E))-1,2,3,4-tetrahydro-4-(oxoethylidene)-2,6-pyridinedicarboxylic acid; (2S,4E)-4-(2-oxoethylidene)-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid |
C9H9NO5 |
211.17 g/mol |
C1C(NC(=CC1=CC=O)C(=O)O)C(=O)O |